Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Penile Cancer
Drug:
carboplatin
(
Tubulin polymerization promoter
) +
paclitaxel
(
Tubulin inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
ESMO.org
Excerpt:
Treatment...chemotherapy for advanced disease...Paclitaxel in combination with carboplatin may provide an alternative regimen in patients who are ineligible for cisplatin treatment.
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.